FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948960687> ?p ?o ?g. }

• W2948960687 endingPage "1719" @default.
• W2948960687 startingPage "1713" @default.
• W2948960687 abstract "Patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation (auto-HCT) are at risk for multiple morbidities, including mucosal inflammation and neutropenic fever, both related to neutropenia. Evidence from our preclinical work in an umbilical cord blood (UCB) transplantation murine model suggests that treatment with hyperbaric oxygen (HBO) before UCB infusion improves UCB CD34+ cell engraftment by reducing erythropoietin levels. A pilot clinical trial using HBO in patients undergoing UCB transplantation showed improvement in kinetics of blood count recovery. In this study, we evaluated HBO in combination with auto-HCT. Our primary aim was to determine the safety of HBO in this setting and secondarily to determine its efficacy in reducing time to neutrophil and platelet engraftment compared with matched historic controls. Patients with multiple myeloma, non-Hodgkin lymphoma, and Hodgkin disease eligible for auto-HCT were included. On day 0, patients received HBO treatment consisting of exposure to 2.5 atmosphere absolutes for a total of 90 minutes, in a monoplace hyperbaric chamber, breathing 100% oxygen. Six hours after the start of HBO, peripherally mobilized stem/progenitor cells were infused and patients were followed daily for toxicity and blood count recovery. All patients received daily granulocyte colony-stimulating factor starting on day +5 and until absolute neutrophil count (ANC) of ≥1500 or ANC of 500 for 3 consecutive days. A matched historic cohort of 225 patients who received auto-HCT between January 2008 and December 2012 was chosen for comparison and matched on sex, age, conditioning regimen, and disease type. We screened 26 patients for this study; 20 were treated and included in the primary analysis, and 19 completed the HBO therapy and were included in the secondary analysis. Although the median time to neutrophil count recovery was 11 days in both the HBO and control cohorts, the Kaplan-Meier estimates of the full distributions indicate that the time to neutrophil recovery was generally about 1 day sooner for HBO versus historical controls (log-rank P = .005; range, 9 to 13 for HBO patients and 7 to 18 for controls). The median time to platelet count recovery was 16 days (range, 14 to 21) for HBO versus 18 days (range, 11 to 86) for controls (log-rank P < .0001). In the secondary analysis comparing the HBO cohort who completed HBO therapy (n = 19) with our historical cohort, we evaluated neutropenic fever, growth factor use, mucositis, day +100 disease responses, and blood product use. HBO was associated with less growth factor use (median 6 days in HBO cohort versus median 8 days in controls, P < .0001). Packed RBC and platelet transfusion requirements were not statistically different between the 2 cohorts. Mucositis incidence was significantly lower in the HBO cohort (26.3% in HBO cohort versus 64.2% in controls, P = .002). HBO therapy appears to be well tolerated in the setting of high-dose therapy and auto-HCT. Prospective studies are needed to confirm potential benefits of HBO with respect to earlier blood count recovery, reduced mucositis, and growth factor use, and a cost-benefit analysis is warranted. © 2019 American Society for Blood and Marrow Transplantation." @default.
• W2948960687 created "2019-06-14" @default.
• W2948960687 creator A5008376636 @default.
• W2948960687 creator A5019735136 @default.
• W2948960687 creator A5035236340 @default.
• W2948960687 creator A5036228481 @default.
• W2948960687 creator A5039680248 @default.
• W2948960687 creator A5039991596 @default.
• W2948960687 creator A5040760454 @default.
• W2948960687 creator A5044257217 @default.
• W2948960687 creator A5052064208 @default.
• W2948960687 creator A5057298244 @default.
• W2948960687 creator A5074130998 @default.
• W2948960687 creator A5074509970 @default.
• W2948960687 creator A5086587597 @default.
• W2948960687 creator A5087265191 @default.
• W2948960687 date "2019-09-01" @default.
• W2948960687 modified "2023-10-16" @default.
• W2948960687 title "Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation" @default.
• W2948960687 cites W1124293988 @default.
• W2948960687 cites W1526986700 @default.
• W2948960687 cites W1755350398 @default.
• W2948960687 cites W1788256932 @default.
• W2948960687 cites W1805076408 @default.
• W2948960687 cites W1840931904 @default.
• W2948960687 cites W1997353354 @default.
• W2948960687 cites W2017416417 @default.
• W2948960687 cites W2043965152 @default.
• W2948960687 cites W2076415895 @default.
• W2948960687 cites W2078583089 @default.
• W2948960687 cites W2086429132 @default.
• W2948960687 cites W2091296960 @default.
• W2948960687 cites W2091346949 @default.
• W2948960687 cites W2097145287 @default.
• W2948960687 cites W2098175638 @default.
• W2948960687 cites W2102591890 @default.
• W2948960687 cites W2111827890 @default.
• W2948960687 cites W2114396320 @default.
• W2948960687 cites W2137546043 @default.
• W2948960687 cites W2150587745 @default.
• W2948960687 cites W2157265657 @default.
• W2948960687 cites W2165021091 @default.
• W2948960687 cites W2314080731 @default.
• W2948960687 cites W2337660074 @default.
• W2948960687 cites W2338376700 @default.
• W2948960687 cites W2536636502 @default.
• W2948960687 cites W2536796599 @default.
• W2948960687 cites W2593787388 @default.
• W2948960687 cites W4246496739 @default.
• W2948960687 doi "https://doi.org/10.1016/j.bbmt.2019.05.028" @default.
• W2948960687 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31170519" @default.
• W2948960687 hasPublicationYear "2019" @default.
• W2948960687 type Work @default.
• W2948960687 sameAs 2948960687 @default.
• W2948960687 citedByCount "5" @default.
• W2948960687 countsByYear W29489606872019 @default.
• W2948960687 countsByYear W29489606872020 @default.
• W2948960687 countsByYear W29489606872022 @default.
• W2948960687 crossrefType "journal-article" @default.
• W2948960687 hasAuthorship W2948960687A5008376636 @default.
• W2948960687 hasAuthorship W2948960687A5019735136 @default.
• W2948960687 hasAuthorship W2948960687A5035236340 @default.
• W2948960687 hasAuthorship W2948960687A5036228481 @default.
• W2948960687 hasAuthorship W2948960687A5039680248 @default.
• W2948960687 hasAuthorship W2948960687A5039991596 @default.
• W2948960687 hasAuthorship W2948960687A5040760454 @default.
• W2948960687 hasAuthorship W2948960687A5044257217 @default.
• W2948960687 hasAuthorship W2948960687A5052064208 @default.
• W2948960687 hasAuthorship W2948960687A5057298244 @default.
• W2948960687 hasAuthorship W2948960687A5074130998 @default.
• W2948960687 hasAuthorship W2948960687A5074509970 @default.
• W2948960687 hasAuthorship W2948960687A5086587597 @default.
• W2948960687 hasAuthorship W2948960687A5087265191 @default.
• W2948960687 hasBestOaLocation W29489606871 @default.
• W2948960687 hasConcept C126322002 @default.
• W2948960687 hasConcept C141071460 @default.
• W2948960687 hasConcept C2776694085 @default.
• W2948960687 hasConcept C2777063308 @default.
• W2948960687 hasConcept C2777408962 @default.
• W2948960687 hasConcept C2777767877 @default.
• W2948960687 hasConcept C2911091166 @default.
• W2948960687 hasConcept C71924100 @default.
• W2948960687 hasConcept C74133956 @default.
• W2948960687 hasConceptScore W2948960687C126322002 @default.
• W2948960687 hasConceptScore W2948960687C141071460 @default.
• W2948960687 hasConceptScore W2948960687C2776694085 @default.
• W2948960687 hasConceptScore W2948960687C2777063308 @default.
• W2948960687 hasConceptScore W2948960687C2777408962 @default.
• W2948960687 hasConceptScore W2948960687C2777767877 @default.
• W2948960687 hasConceptScore W2948960687C2911091166 @default.
• W2948960687 hasConceptScore W2948960687C71924100 @default.
• W2948960687 hasConceptScore W2948960687C74133956 @default.
• W2948960687 hasIssue "9" @default.
• W2948960687 hasLocation W29489606871 @default.
• W2948960687 hasLocation W29489606872 @default.
• W2948960687 hasOpenAccess W2948960687 @default.
• W2948960687 hasPrimaryLocation W29489606871 @default.
• W2948960687 hasRelatedWork W2017298652 @default.

• next